As of January 2025, Hemogenyx Pharmaceuticals has a market cap of $5.46B. This makes Hemogenyx Pharmaceuticals the world's 2500th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $45.29M | 33.48% |
2023 | $33.93M | 73.58% |
2022 | $19.55M | -29.33% |
2021 | $27.66M | -80.57% |
2020 | $142.37M | 394.87% |
2019 | $28.77M | -7.14% |
2018 | $30.98M | -16.00% |
2017 | $36.88M | -33.33% |
2016 | $55.33M | 0.00% |
2015 | $55.33M | - |